Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe

Dr Reddy’s Laboratories has received marketing approval from the European Commission (EC) for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab) prescribed in the treatment of bone related conditions,…